Literature DB >> 11735102

The role of platelets in decrypting monocyte tissue factor.

B Osterud1.   

Abstract

Although about 80% of tissue factor (TF) extracellular domain antigen present in lipopolysaccharide (LPS)-stimulated monocytes is available at the cell surface, only 10% to 20% of the total extractable TF activity is expressed on the surface of intact monocytes. Thus, most of the TF activity is latent or encrypted in the cell membrane. When coincubated, leukocytes and platelets generate more TF activity than either cell type alone. We have shown that such platelet-promoted enhancement of LPS-induced TF activity in monocytes in whole blood depends on neutrophil involvement in a P-selectin/CD15 (a leukocyte membrane-bound carbohydrate)-dependent reaction. The effect was even more pronounced when both the phorbol ester, phorbol 12-myristate 13-acetate (PMA), and LPS were present during monocyte stimulation. We currently envisage that decryption is mediated through the secretion of TF-rich particles by monocytes. These particles express CD15 and bind P-selectin exposed on either activated platelets or platelet-derived microparticles. Interactions and fusion events, that typically occur between monocytes and platelets, would facilitate the generation of monocytes/monocyte microparticle and platelets/platelet microparticle hybrids, leading to particles rich in decrypted TF activity. In conclusion, platelets play a pivotal role in decrypting TF activity of monocytes, generating a hybrid TF terrain, which both triggers and favors thrombogenesis. Copyright 2001 by W.B. Saunders Company.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11735102     DOI: 10.1016/s0037-1963(01)90139-8

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  14 in total

1.  Tissue factor activity in women with preeclampsia or SGA: a potential explanation for the excessive thrombin generation in these syndromes.

Authors:  Offer Erez; Roberto Romero; Edi Vaisbuch; Nandor Gabor Than; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Francesca Gotsch; Pooja Mittal; Zhong Dong; Tinnakorn Chaiworapongsa; Chong Jai Kim; Chia-Ling Nhan-Chang; Sun Kwon Kim; Lami Yeo; Moshe Mazor; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2017-05-19

2.  Differential inhibitory effect of fondaparinux on the procoagulant potential of intact monocytes and monocyte-derived microparticles.

Authors:  Sonia Ben-Hadj-Khalifa-Kechiche; Nathalie Hezard; Stephane Poitevin; Marie-Geneviève Remy; Bernadette Florent; Touhami Mahjoub; Philippe Nguyen
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

Review 3.  Tissue factor in coagulation: Which? Where? When?

Authors:  Saulius Butenas; Thomas Orfeo; Kenneth G Mann
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-10       Impact factor: 8.311

4.  Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas.

Authors:  Mark Wahrenbrock; Lubor Borsig; Dzung Le; Nissi Varki; Ajit Varki
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

5.  Changes in amniotic fluid concentration of thrombin-antithrombin III complexes in patients with preterm labor: evidence of an increased thrombin generation.

Authors:  Offer Erez; Roberto Romer; Edi Vaisbuch; Tinnakorn Chaiworapongsa; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Francesca Gotsch; Ricardo Gomez; Eli Maymon; Percy Pacora; Samuel S Edwin; Chong Jai Kim; Nandor Gabor Than; Pooja Mittal; Lami Yeo; Zhong Dong; Bo Hyun Yoon; Sonia S Hassan; Moshe Mazor
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11

6.  Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis.

Authors:  Eduardo Ramacciotti; Angela E Hawley; Diana M Farris; Nicole E Ballard; Shirley K Wrobleski; Daniel D Myers; Peter K Henke; Thomas W Wakefield
Journal:  Thromb Haemost       Date:  2009-04       Impact factor: 5.249

Review 7.  Tissue factor: a key molecule in hemostatic and nonhemostatic systems.

Authors:  James H Morrissey
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

8.  Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia.

Authors:  Giovanna Oggé; Roberto Romero; Tinnakorn Chaiworapongsa; Maria Teresa Gervasi; Percy Pacora; Offer Erez; Juan Pedro Kusanovic; Edi Vaisbuch; Shali Mazaki-Tovi; Francesca Gotsch; Pooja Mittal; Yeon Mee Kim; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-06

9.  Tissue factor and its natural inhibitor in pre-eclampsia and SGA.

Authors:  Offer Erez; Roberto Romero; Debra Hoppensteadt; Nandor Gabor Than; Jawed Fareed; Shali Mazaki-Tovi; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Sung-Su Kim; Bo Hyun Yoon; Sonia S Hassan; Francesca Gotsch; Lara Friel; Edi Vaisbuch; Juan Pedro Kusanovic
Journal:  J Matern Fetal Neonatal Med       Date:  2008-12

10.  The nature of the stable blood clot procoagulant activities.

Authors:  Thomas Orfeo; Kathleen E Brummel-Ziedins; Matthew Gissel; Saulius Butenas; Kenneth G Mann
Journal:  J Biol Chem       Date:  2008-02-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.